---
figid: PMC4657124__WJBC-6-290-g001
figlink: /pmc/articles/PMC4657124/figure/F1/
number: Figure 1
caption: 'The Wnt/β-catenin signaling pathway. A: In the absence of a Wnt ligand,
  cytoplasmic β-catenin is targeted for proteasomal degradation by a multi-protein
  “destruction complex”. Within the nucleus, TCF/Lef at WREs associates with the TLE
  co-repressor to repress Wnt/β-catenin target gene expression; B: Upon Wnt ligand
  binding to the FZD and LRP5/6 co-receptor complex, AXIN1/2 is recruited to the plasma
  membrane and the destruction complex is inactivated. β-Catenin subsequently translocates
  to the nucleus where it binds TCF/Lef assembled at WREs and recruits co-activator
  complexes to activate Wnt/β-catenin target gene expression; C: In CRCs, truncations
  of the APC protein prevent efficient targeting of β-catenin for proteasomal degradation.
  Therefore, nuclear β-catenin levels are elevated and aberrantly associate with TCF/Lef
  at WREs to drive deregulated expression of Wnt/β-catenin target genes. WRE: Wnt
  responsive DNA element; TCF/Lef: T-cell factor/Lymphoid enhancer factor; TLE: Transducin-like
  enhancer; FZD: Frizzled; LRP5/6: Lipoprotein receptor-related protein 5 or 6; AXIN1/2:
  Axis inhibition proteins 1 and/or 2; CRC: Colorectal cancer; APC: Adenomatous polyposis
  coli; GSK3: Glycogen synthase kinase three; CK1: Casein kinase 1.'
pmcid: PMC4657124
papertitle: Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling
  in colorectal cancer.
reftext: Sherri Rennoll, et al. World J Biol Chem. 2015 Nov 26;6(4):290-300.
pmc_ranked_result_index: '49311'
pathway_score: 0.9457064
filename: WJBC-6-290-g001.jpg
figtitle: Wnt/Beta-catenin signaling pathway
year: '2015'
organisms: Homo sapiens
ndex: c41ef079-deaa-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4657124__WJBC-6-290-g001.html
  '@type': Dataset
  description: 'The Wnt/β-catenin signaling pathway. A: In the absence of a Wnt ligand,
    cytoplasmic β-catenin is targeted for proteasomal degradation by a multi-protein
    “destruction complex”. Within the nucleus, TCF/Lef at WREs associates with the
    TLE co-repressor to repress Wnt/β-catenin target gene expression; B: Upon Wnt
    ligand binding to the FZD and LRP5/6 co-receptor complex, AXIN1/2 is recruited
    to the plasma membrane and the destruction complex is inactivated. β-Catenin subsequently
    translocates to the nucleus where it binds TCF/Lef assembled at WREs and recruits
    co-activator complexes to activate Wnt/β-catenin target gene expression; C: In
    CRCs, truncations of the APC protein prevent efficient targeting of β-catenin
    for proteasomal degradation. Therefore, nuclear β-catenin levels are elevated
    and aberrantly associate with TCF/Lef at WREs to drive deregulated expression
    of Wnt/β-catenin target genes. WRE: Wnt responsive DNA element; TCF/Lef: T-cell
    factor/Lymphoid enhancer factor; TLE: Transducin-like enhancer; FZD: Frizzled;
    LRP5/6: Lipoprotein receptor-related protein 5 or 6; AXIN1/2: Axis inhibition
    proteins 1 and/or 2; CRC: Colorectal cancer; APC: Adenomatous polyposis coli;
    GSK3: Glycogen synthase kinase three; CK1: Casein kinase 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD1
  - FZD4
  - FZD3
  - WNT5A
  - WNT6
  - TLE1
  - FZD7
  - WNT8A
  - WNT8B
  - WNT7A
  - WNT3
  - FZD2
  - FZD5
  - TLE6
  - FZD6
  - TLE3
  - TLE4
  - APC
  - TLE2
  - WNT2B
  - WNT9A
  - WNT3A
  - WNT11
  - WNT2
  - TLE7
  - WNT7B
  - GSK3B
  - FZD8
  - FZD9
  - GSK3A
  - WNT1
  - WNT10A
  - FZD10
  - WNT5B
  - WNT16
  - WNT10B
  - LRP5
  - LRP6
  - WNT4
  - WNT9B
genes:
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE1
  entrez: '7088'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE6
  entrez: '79816'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE3
  entrez: '7090'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE4
  entrez: '7091'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE2
  entrez: '7089'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE7
  entrez: '102723796'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: FZD,
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
chemicals: []
diseases: []
---
